Plus Therapeutics (PSTV) Misses Q1 EPS by 75c
Plus Therapeutics (NASDAQ: PSTV) reported Q1 EPS of ($0.75). Revenue for the quarter came in at $1.67 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Plus Therapeutics (NASDAQ: PSTV) reported Q1 EPS of ($0.75). Revenue for the quarter came in at $1.67 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.